Transcriptome profile of OVCAR3 cisplatin-resistant ovarian cancer cell line

por Sakhare, Shruti S, Rao, Gautam G, Mandape, Sammed N, Pratap, Siddharth
Publicado 2014

Barriers to Timely Completion of Radiation Therapy in Patients with Cervical Cancer in an Urban Tertiary Care Center

por Cohen, Justin, Harper, Amy, Nichols, Elizabeth M, Rao, Gautam G, Mohindra, Pranshu, Roque, Dana Marie
Publicado 2017

EP4 and Class III β-Tubulin Expression in Uterine Smooth Muscle Tumors: Implications for Prognosis and Treatment

por Reader, Jocelyn, Harper, Amy K., Legesse, Teklu, Staats, Paul N., Goloubeva, Olga, Rao, Gautam G., Fulton, Amy, Roque, Dana M.
Publicado 2019

Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases

por Duru, Nadire, Pawar, Nisha R., Martin, Erik W., Buzza, Marguerite S., Conway, Gregory D., Lapidus, Rena G., Liu, Shihui, Reader, Jocelyn, Rao, Gautam G., Roque, Dana M., Leppla, Stephen H., Antalis, Toni M.
Publicado 2022

Microtentacle Formation in Ovarian Carcinoma

por Reader, Jocelyn C., Fan, Cong, Ory, Eleanor Claire-Higgins, Ju, Julia, Lee, Rachel, Vitolo, Michele I., Smith, Paige, Wu, Sulan, Ching, Mc Millan Nicol, Asiedu, Emmanuel B., Jewell, Christopher M., Rao, Gautam G., Fulton, Amy, Webb, Tonya J., Yang, Peixin, Santin, Alessandro D., Huang, Huang-Chiao, Martin, Stuart S., Roque, Dana M.
Publicado 2022

Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer

por Roque, Dana M., Siegel, Eric R., Buza, Natalia, Bellone, Stefania, Silasi, Dan-Arin, Huang, Gloria S., Andikyan, Vaagn, Clark, Mitchell, Azodi, Masoud, Schwartz, Peter E., Rao, Gautam G., Reader, Jocelyn C., Hui, Pei, Tymon-Rosario, Joan R., Harold, Justin, Mauricio, Dennis, Zeybek, Burak, Menderes, Gulden, Altwerger, Gary, Ratner, Elena, Santin, Alessandro D.
Publicado 2022